in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – June 26
10:21 AM MDT | June 26, 2012 | Deepti Ramesh
HOVIONE REPORTS RISE IN SALES Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) has recorded a 24% rise in sales in the fiscal year ended March 31, 2012, compared with the previous fiscal year, to $180 million. Earnings figures were not disclosed. “During the last five years Hovione has doubled its sales and has made bold strategic steps to both strengthen its ability to serve innovators and to consolidate its leadership in off-patent contrast agents,” says Miguel Calado, chief financial officer at Hovione. “Looking...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee